Business Description
CanSino Biologics Inc
ISIN : CNE100003F01
Share Class Description:
HKSE:06185: Class HCompare
Compare
Traded in other countries / regions
688185.China06185.Hong KongCJH.GermanyCASBF.USA IPO Date
2019-03-28Description
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing and commercialization of vaccine products for human use. These include products such as pneumococcal polysaccharide and conjugate vaccines as well as a DTcP-based combo and other items. At the same time, the group is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine. Geographically, the activities are carried out through China.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.53 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.51 | |||||
| Debt-to-EBITDA | -4.11 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 0.92 | |||||
| Beneish M-Score | -3.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 152.5 | |||||
| 3-Year EBITDA Growth Rate | -57.3 | |||||
| 3-Year EPS without NRI Growth Rate | -44.6 | |||||
| 3-Year FCF Growth Rate | -21.2 | |||||
| 3-Year Book Growth Rate | -7.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.94 | |||||
| 9-Day RSI | 61.03 | |||||
| 14-Day RSI | 57.92 | |||||
| 6-1 Month Momentum % | -32.19 | |||||
| 12-1 Month Momentum % | -59.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2 | |||||
| Quick Ratio | 1.86 | |||||
| Cash Ratio | 1.59 | |||||
| Days Inventory | 399.3 | |||||
| Days Sales Outstanding | 859.76 | |||||
| Days Payable | 142.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 2.06 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -35.67 | |||||
| Operating Margin % | -234.78 | |||||
| Net Margin % | -198.85 | |||||
| FCF Margin % | -475.44 | |||||
| ROE % | -10.76 | |||||
| ROA % | -6.33 | |||||
| ROIC % | -12.67 | |||||
| ROC (Joel Greenblatt) % | -21.28 | |||||
| ROCE % | -8.89 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 13.47 | |||||
| PB Ratio | 0.82 | |||||
| Price-to-Tangible-Book | 0.86 | |||||
| EV-to-EBIT | -10.07 | |||||
| EV-to-EBITDA | -10.07 | |||||
| EV-to-Revenue | 20.62 | |||||
| EV-to-FCF | -4.24 | |||||
| Price-to-Net-Current-Asset-Value | 3.82 | |||||
| Price-to-Net-Cash | 56.41 | |||||
| Earnings Yield (Greenblatt) % | -9.93 | |||||
| FCF Yield % | -19.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CanSino Biologics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 351.232 | ||
| EPS (TTM) (HK$) | -6.561 | ||
| Beta | 0.47 | ||
| Volatility % | 51.14 | ||
| 14-Day RSI | 57.92 | ||
| 14-Day ATR (HK$) | 0.993064 | ||
| 20-Day SMA (HK$) | 17.518 | ||
| 12-1 Month Momentum % | -59.84 | ||
| 52-Week Range (HK$) | 14.8 - 38.05 | ||
| Shares Outstanding (Mil) | 247.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CanSino Biologics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CanSino Biologics Inc Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
CanSino Biologics Inc Frequently Asked Questions
What is CanSino Biologics Inc(HKSE:06185)'s stock price today?
The current price of HKSE:06185 is HK$19.18. The 52 week high of HKSE:06185 is HK$38.05 and 52 week low is HK$14.80.
When is next earnings date of CanSino Biologics Inc(HKSE:06185)?
The next earnings date of CanSino Biologics Inc(HKSE:06185) is 2024-04-29 Est..
Does CanSino Biologics Inc(HKSE:06185) pay dividends? If so, how much?
CanSino Biologics Inc(HKSE:06185) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers